Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02738099 · ClinicalTrials.gov registry record

Risk Stratification of Patients Presenting With Cardiac Arrest

A clinical trial, sponsored by Essentia Health.

Completed
Registry status
100
Enrollment target

NCT02738099: Completed study, sponsored by Essentia Health.

NCT02738099 is a clinical trial that has completed, run by Essentia Health. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02738099 has completed, sponsored by Essentia Health.

COMPLETED
Registry status
100 participants
Enrollment target

Study Summary

Method: Single center, prospective, non-randomized, unblinded case series of all patients presenting with a cardiac arrest. The proposed study will collect data on all comatose patients presenting with cardiac arrest. The primary end point is death from any cause at 30 days from admission. Significance: Develop criteria to guide an invasive strategy for comatose patients presenting with cardiac arrest, and so avoid ineffective or even futile therapy which carry its own significant risks for patients in the future. The criteria, in turn, can serve as the basis for a prospective, randomized trial in the future.

Primary Outcome

Death from any cause at 30 days from admission

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2016-04
Est. Completion 2020-05-01
Essentia Health

17 total trials

What the finished NCT02738099 record still lists

NCT02738099 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT02738099 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02738099 about?

NCT02738099 is a clinical study titled "Risk Stratification of Patients Presenting With Cardiac Arrest". Method: Single center, prospective, non-randomized, unblinded case series of all patients presenting with a cardiac arrest. The proposed study will collect data on all comatose patients presenting with cardiac arrest. The primary end point is death from any cause at 30 days from admission. Signific...

What is the current status of trial NCT02738099?

This trial is currently completed. The enrollment target is 100 participants. The study started on 2016-04. Estimated completion is 2020-05-01.

Who is sponsoring clinical trial NCT02738099?

This trial is sponsored by Essentia Health, which has 17 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02738099, the US trial registry maintained by the National Library of Medicine. NCT02738099 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.